About This Publication:

  • Print This Page
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Cancer Biotherapy and Radiopharmaceuticals

Editors: Donald J. Buchsbaum, PhD and Robert K. Oldham, MD

ISSN: 1084-9785 • Online ISSN: 1557-8852 • 10 Issues Annually

Current Volume: 30

Latest Impact Factor* is 1.381

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

Featured Press Releases and Editorial Content

  • Can Personalized Tumor Vaccines Improve Survival of Patients with Interleukin-2 Treated Metastatic Melanoma? Read Now
  • Can the Addition of Radiolabeled Treatments Improve Outcomes in Advanced Metastatic Disease?...Read Press Release
    • Perspective by Dr. Turner...Read Now
    • Article by Drs. Kruger, Cooney, and Turner...Read Now
    • Article by Drs. Claringbold, Price, and Turner....Read Now
  • Promising Early Results with Therapeutic Cancer Vaccines...Read Press Release Now
    • Should High-Dose Interleukin-2 Continue to be the Treatment of Choice for Metastatic Melanoma?..Read Now
    • Perspective by Dr. Schlom...Read Now
    • Article by Drs. Hodge, Sharp, and Gameiro...Read Now
    • Article by Drs. Gameiro, Caballero, and Hodge....Read Now


Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments. 

Cancer Biotherapy and Radiopharmaceuticals coverage includes:

  • Antibody drug conjugates
  • Fusion toxins and immunotoxins
  • Nanoparticle therapy
  • Vascular therapy
  • Inhibitors of proliferation signaling pathways

Cancer Biotherapy and Radiopharmaceuticals is under the editorial leadership of Editors Donald J. Buchsbaum, PhD, Division of Radiation Biology, Department of Radiation Oncology, University of Alabama at Birmingham; Robert K. Oldham, MD, Lower Keys Cancer Center; and other leading investigators. View the entire editorial board.

Audience: Oncologists, nuclear medicine researchers, radiologists, cancer researchers, pathologists, and epidemiologists, among others.

Indexed/Abstracted in:

MEDLINE; PubMed; PubMed Central; Current Contents®/Life Sciences; Current Contents®/Clinical Medicine; Science Citation Index Expanded; Science Citation Index®; Biological Abstracts; BIOSIS Previews; Journal Citation Reports/Science Edition; Prous Science Integrity®; Derwent Drug File; EMBASE/Excerpta Medica; Scopus; EMCare; ProQuest; CAB Abstracts; Global Health; SIIC Data Bases

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Journal of Interferon
    & Cytokine Research

    Journal of Interferon
    & Cytokine Research

    Presents the latest findings and reviews of research covering IFNs and cytokines, their relevance to chronic and acute disease, studies involving cytokine biology, mechanisms of IFN action, and their role in virus infection.

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    ASSAY and Drug Development Technologies

    ASSAY and Drug Development Technologies

    This authoritative, rapidly peer-reviewed journal features original articles, application-oriented technology reviews, and reports in methodology and technology application.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

Browse All Publications »